Can-Fite BioPharma launches best-efforts offering of ADSs and warrants

1 day ago 1

Can-Fite BioPharma (NYSE:CANF) is offering up to 4.9 million ADSs (representing 1.47 billion ordinary shares) and 4.9 million common warrants in a best-efforts offering.
Each ADS will be sold with one common warrant at an assumed combined price of $1.02/unit.

Recommended For You